We are live on ! Find out more
RG

Renaissance Group Portfolio holdings

AUM $2.46B
1-Year Est. Return 32.78%
This Fund
S&P 500
This Quarter Est. Return
+1.97%
1 Year Est. Return
+32.78%
3 Year Est. Return
+114.54%
5 Year Est. Return
+163.28%
10 Year Est. Return
+573.7%
AUM
$2.49B
AUM Growth
-$160M
Cap. Flow
-$136M
Cap. Flow %
-5.47%
Top 10 Hldgs %
17.57%
Holding
255
New
16
Increased
77
Reduced
144
Closed
15
Avg Time Held
13.1 quarters
Top 10 Avg Time Held
1.4 quarters
Top 20 Avg Time Held
3.9 quarters

Top Buys

Rank Stock Value
1
SCHW icon
Charles Schwab
SCHW
+$33.2M
2
PEGA icon
Pegasystems
PEGA
+$31.7M
3
LRCX icon
Lam Research
LRCX
+$31.4M
4
BSX icon
Boston Scientific
BSX
+$28.9M
5
PRVA icon
Privia Health
PRVA
+$7.98M

Top Sells

Rank Stock Value
1
WM icon
Waste Management
WM
+$29.8M
2
RCL icon
Royal Caribbean
RCL
+$29.7M
3
BRO icon
Brown & Brown
BRO
+$23.5M
4
FISV icon
Fiserv Inc
FISV
+$17.6M
5
FIX icon
Comfort Systems
FIX
+$12.8M

Sector Composition

Rank Sector Weight
1 Technology 36.38%
2 Healthcare 15.24%
3 Financials 12.91%
4 Industrials 9.59%
5 Consumer Discretionary 9.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ADSK icon
51
Autodesk
ADSK
$48.4B
$22.7M 0.91%
76,827
-29,539
-28% -$8.94M
2025 Q3
1 quarter
PINS icon
52
Pinterest
PINS
$12.4B
$20.6M 0.83%
797,189
-202,989
-20% -$5.84M
2024 Q4
4 quarters
DT icon
53
Dynatrace
DT
$18.5B
$19.9M 0.8%
458,055
-61,471
-12% -$2.87M
2025 Q2
2 quarters
CPRT icon
54
Copart
CPRT
$24.1B
$19.2M 0.77%
490,396
-65,373
-12% -$2.71M
2025 Q1
3 quarters
NTNX icon
55
Nutanix
NTNX
$19.3B
$17.9M 0.72%
345,664
-96,165
-22% -$5.88M
2025 Q2
2 quarters
TSM icon
56
TSMC
TSM
$2.24T
$12.1M 0.49%
39,947
-6,250
-14% -$1.83M
2013 Q2
50 quarters
MEDP icon
57
Medpace
MEDP
$17.2B
$11.3M 0.45%
20,042
+116
+0.6% +$65.8K
2019 Q2
26 quarters
ENSG icon
58
The Ensign Group
ENSG
$10.2B
$10.7M 0.43%
61,667
+433
+0.7% +$77.8K
2024 Q1
7 quarters
HURN icon
59
Huron Consulting
HURN
$2.79B
$10.4M 0.42%
60,388
-9,634
-14% -$1.58M
2024 Q1
7 quarters
CWAN icon
60
DELISTED
Clearwater Analytics
CWAN
$10.1M 0.4%
417,761
-28,528
-6% -$571K
2025 Q2
2 quarters
RMBS icon
61
Rambus
RMBS
$10.2B
$10M 0.4%
108,775
+308
+0.3% +$30.3K
2024 Q2
6 quarters
TIGO icon
62
Millicom
TIGO
$13.5B
$9.98M 0.4%
180,034
-21,873
-11% -$1.1M
2022 Q2
14 quarters
FLEX icon
63
Flex
FLEX
$37.3B
$9.54M 0.38%
157,814
-16,503
-9% -$1.02M
2024 Q3
5 quarters
STRL icon
64
Sterling Infrastructure
STRL
$14.1B
$9.5M 0.38%
31,031
+201
+0.7% +$69.3K
2021 Q1
19 quarters
TMDX icon
65
Transmedics
TMDX
$2.65B
$9.39M 0.38%
77,229
+1,151
+2% +$144K
2025 Q3
1 quarter
CRH icon
66
CRH
CRH
$52.3B
$9.39M 0.38%
75,261
-5,802
-7% -$691K
2017 Q1
35 quarters
PI icon
67
Impinj
PI
$5.54B
$9.18M 0.37%
52,756
-3,478
-6% -$620K
2025 Q1
3 quarters
TEVA icon
68
Teva Pharmaceutical Industries Limited
TEVA
$48.4B
$9.11M 0.37%
291,915
-22,655
-7% -$558K
2024 Q2
6 quarters
CRDO icon
69
Credo Technology Group
CRDO
$34.3B
$9.07M 0.36%
63,007
-23,921
-28% -$3.68M
2024 Q3
5 quarters
PLMR icon
70
Palomar
PLMR
$3.54B
$9.01M 0.36%
66,895
-6,294
-9% -$768K
2024 Q1
7 quarters
JAZZ icon
71
Jazz Pharmaceuticals
JAZZ
$13.9B
$8.89M 0.36%
52,314
+3,211
+7% +$492K
2025 Q1
3 quarters
CTRE icon
72
CareTrust REIT
CTRE
$8.62B
$8.89M 0.36%
245,779
+2,365
+1% +$84.8K
2020 Q4
20 quarters
ADMA icon
73
ADMA Biologics
ADMA
$2.36B
$8.68M 0.35%
475,679
-40,909
-8% -$689K
2025 Q2
2 quarters
UFPT icon
74
UFP Technologies
UFPT
$2.25B
$8.45M 0.34%
38,064
-3,775
-9% -$809K
2025 Q1
3 quarters
FTI icon
75
TechnipFMC
FTI
$27.2B
$8.44M 0.34%
189,410
-13,241
-7% -$559K
2025 Q2
2 quarters

Similar funds

Renaissance Group's Q4 2025 Portfolio in Review

As of Q4 2025, Renaissance Group held 255 positions worth $2.49B, down 6.1% from $2.65B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Renaissance Group withdrew a net $136M in Q4 2025, closing 15 positions and reducing 144 holdings. Its most notable exit was Brown & Brown, an estimated $23.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Renaissance Group opened a new position in Charles Schwab worth $35M.

  • Renaissance Group's largest Q4 2025 buy was Charles Schwab: 349,890 shares worth $35M.
  • Renaissance Group added most to Lam Research in Q4 2025, an estimated $31.4M increase.
  • Renaissance Group's biggest Q4 2025 reduction was Waste Management, cutting an estimated $29.8M.
  • Renaissance Group fully exited Brown & Brown in Q4 2025, selling an estimated $23.5M.
  • Renaissance Group's ten largest holdings make up 18% of its $2.49B portfolio in Q4 2025.
  • Renaissance Group opened 16 new positions and closed 15 in Q4 2025.
  • Renaissance Group's portfolio value fell 6.1% quarter-over-quarter to $2.49B.

Based on Renaissance Group's 13F filing for Q4 2025, filed 11 Feb 2026.